Soundbite Crossing System Peripheral First in Man

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Peripheral Artery Disease
Interventions
DEVICE

CTO Crossing

With confirmation that the target vessel is completely occluded by the target CTO lesion, the operator shall initially attempt crossing the proximal end of the target CTO lesion by advancing ShockWireTM device ≥ 1cm. The SoundBite Crossing device can be activated as needed to perform the procedure and may be used for the entire length of the lesion(s).

Trial Locations (2)

H2W 1T8

CHUM - Centre Hospitalier de l'Université de Montreal - Hôtel-Dieu, Montreal

J1H 5N4

CHUS - Centre Hospitalier Universitaire de Sherbrooke - Freurimont, Sherbrooke

All Listed Sponsors
lead

SoundBite Medical Solutions, Inc.

INDUSTRY

NCT03013088 - Soundbite Crossing System Peripheral First in Man | Biotech Hunter | Biotech Hunter